AGENTS AND METHODS TO ELICIT ANTI-TUMOR IMMUNE RESPONSE Read more about AGENTS AND METHODS TO ELICIT ANTI-TUMOR IMMUNE RESPONSE Finland07838099.5Filed on 2007-09-13
AGENTS AND METHODS TO ELICIT ANTI-TUMOR IMMUNE RESPONSE Read more about AGENTS AND METHODS TO ELICIT ANTI-TUMOR IMMUNE RESPONSE Spain07838099.5Filed on 2007-09-13
AGENTS AND METHODS TO ELICIT ANTI-TUMOR IMMUNE RESPONSE Read more about AGENTS AND METHODS TO ELICIT ANTI-TUMOR IMMUNE RESPONSE Denmark07838099.5Filed on 2007-09-13
AGENTS AND METHODS TO ELICIT ANTI-TUMOR IMMUNE RESPONSE Read more about AGENTS AND METHODS TO ELICIT ANTI-TUMOR IMMUNE RESPONSE Germany07838099.5Filed on 2007-09-13
AGENTS AND METHODS TO ELICIT ANTI-TUMOR IMMUNE RESPONSE Read more about AGENTS AND METHODS TO ELICIT ANTI-TUMOR IMMUNE RESPONSE Switzerland07838099.5Filed on 2007-09-13
AGENTS AND METHODS TO ELICIT ANTI-TUMOR IMMUNE RESPONSE Read more about AGENTS AND METHODS TO ELICIT ANTI-TUMOR IMMUNE RESPONSE Austria07838099.5Filed on 2007-09-13
PROGNOSTIC MARKERS AND METHODS FOR PROSTATE CANCER Read more about PROGNOSTIC MARKERS AND METHODS FOR PROSTATE CANCER European Patent10849985.6Filed on 2010-08-12
ANTI-PY1235-MET IMMUNOLOGICAL BINDING REAGENT Read more about ANTI-PY1235-MET IMMUNOLOGICAL BINDING REAGENT Patent Cooperation TreatyPCT/US2017/022783Filed on 2017-03-16
Methods of Conditioning Patients For T Cell Therapy Read more about Methods of Conditioning Patients For T Cell Therapy US Application 15/295,931Filed on 2016-10-17
Immunogenic Modulation By Endocrine Deprivation Therapy Improves Sensitivity Of Tumor Cells To Immune Mediated Lysis Read more about Immunogenic Modulation By Endocrine Deprivation Therapy Improves Sensitivity Of Tumor Cells To Immune Mediated Lysis US Application 15/507,316Filed on 2017-02-28